Merck asks FDA to clear Gardasil for boys, young men
Merck & Co. requested that the FDA expand the use of the company's cervical cancer vaccine Gardasil to males ages 9 to 26 to protect them against genital warts and other kinds of lesions. Merck also awaits U.S. clearance for Gardasil's use in preventing human papillomavirus infection in 27- to 45-year-old women.
CNBC | 01/05
This story published in AANP SmartBrief on 01/06/2009
More from SmartBrief:
Gardasil protects older women, gay men in separate studies
Thursday, February 18, 2010
Free HPV vaccine program reduces cases of genital warts
Friday, July 10, 2009
FDA approves Gardasil for boys, young men
Monday, October 19, 2009
Get stories like these delivered daily for FREE:
|
AANP SmartBrief
Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more |
|